Publication|Articles|February 17, 2025
- Pharmaceutical Executive: February 2025
- Volume 45
- Issue 1
Pharmaceutical Executive: February 2025 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2025 issue in an interactive PDF format.
Advertisement
Articles in this issue
10 months ago
At First Glance10 months ago
2025 Pipeline Report: The Edge of Greatness?10 months ago
Inclusive Marketing: Engaging with Purpose10 months ago
The Shifting Pharmacy Landscape in 202510 months ago
Navigating the EU’s Joint Clinical Assessment10 months ago
AI: Hungry for PowerNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Preview: Roche’s Refresh
2
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
3
AstraZeneca Reaches $2 Billion License Agreement with Jacobio Pharma for Pan-KRAS Inhibitor
4
JP Morgan 2026 Preview: Eli Lilly Seeks Bounce Back
5

